Paper3373659
Characterization of antihypertensive therapy by whole-day blood pressure monitoring.
Weber MA and 3 others. JAMA, 1988. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. Papers, record 3373659. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3373659
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Pressure Determination | Major topic |
| Diltiazem | Major topic |
| Hypertension | Major topic |
| Adult | |
| Aged | |
| Body Weight | |
| Double-Blind Method | |
| Female | |
| Heart Rate | |
| Humans | |
| Male | |
| Middle Aged | |
| Monitoring, Physiologic |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24667908 | An analysis of 24-h ambulatory blood pressure monitoring data using orthonormal polynomials in the linear mixed model. | Blood Press Monit | 2014 | https://conductscience.org/library/papers/24667908 | PubMed |
| 17215652 | Ambulatory blood pressure monitoring as an investigative tool for characterizing resistant hypertension and its rational treatment. | J Clin Hypertens (Greenwich) | 2007 | https://conductscience.org/library/papers/17215652 | PubMed |
| 16596026 | An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements. | J Clin Hypertens (Greenwich) | 2006 | https://conductscience.org/library/papers/16596026 | PubMed |
| 15361888 | Comparing office-based and ambulatory blood pressure monitoring in clinical trials. | J Hum Hypertens | 2005 | https://conductscience.org/library/papers/15361888 | PubMed |
| 10981177 | Treatment of white coat hypertension. | Curr Hypertens Rep | 2000 | https://conductscience.org/library/papers/10981177 | PubMed |
| 10155311 | Defining the patient group for cost-effective withdrawal of antihypertensive therapy. | Pharmacoeconomics | 1995 | https://conductscience.org/library/papers/10155311 | PubMed |
| 8443029 | Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8443029 | PubMed |
| 8403162 | Vasodilators during cerebral aneurysm surgery. | Can J Anaesth | 1993 | https://conductscience.org/library/papers/8403162 | PubMed |
| 8369596 | Diltiazem. A review of its pharmacology and therapeutic use in older patients. | Drugs Aging | 1993 | https://conductscience.org/library/papers/8369596 | PubMed |
| 7917870 | Clinical uses of ambulatory blood pressure monitoring. | Pediatr Nephrol | 1994 | https://conductscience.org/library/papers/7917870 | PubMed |
| 7894213 | Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. | Clin Investig | 1994 | https://conductscience.org/library/papers/7894213 | PubMed |
| 7512472 | Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors? | Drugs | 1993 | https://conductscience.org/library/papers/7512472 | PubMed |
| 2191851 | Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. | Drugs | 1990 | https://conductscience.org/library/papers/2191851 | PubMed |
| 2081142 | Verapamil 240 SR versus verapamil 120 SR in arterial hypertension. A randomized double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2081142 | PubMed |
| 1888693 | Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension. | Cardiovasc Drugs Ther | 1991 | https://conductscience.org/library/papers/1888693 | PubMed |
| 1618242 | Ambulatory blood pressure monitoring for the assessment of nicardipine as a third drug in severe essential hypertension. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1618242 | PubMed |
| 1352496 | Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs bisoprolol. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1352496 | PubMed |
| 1283574 | Use of ambulatory blood pressure monitoring in the management of antihypertensive therapy. | Drugs | 1992 | https://conductscience.org/library/papers/1283574 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3373659
GET https://conductscience.org/api/papers/v1/3373659/authors